Bladder cancer: evaluation of staging accuracy using dynamic MRI

Area of Science:

• Oncology
• Radiology
• Urology

Background:

• Accurate staging of bladder cancer is crucial for treatment planning.
• Magnetic resonance imaging (MRI) is a key modality for assessing tumor extent.

Purpose of the Study:

• To evaluate the accuracy of MRI in determining the T stage of bladder cancer.
• To determine if dynamic gadolinium-enhanced MRI sequences improve staging accuracy.

Main Methods:

• Retrospective review of MRI findings in 100 patients with transitional cell carcinoma (TCC) of the bladder.
• Independent assessment of T stage using T2-weighted imaging alone and with gadolinium-enhanced sequences.
• Comparison of MRI staging with final histological diagnosis.

Main Results:

• MRI correctly staged tumors on a stage-by-stage basis in 63% of patients (kappa=0.57).
• MRI demonstrated 78.2% sensitivity and 93.3% specificity for differentiating superficial (≤T1) from invasive (≥T2) disease.
• MRI showed 90.5% sensitivity and 60% specificity for differentiating organ-confined (≤T2) from non-organ-confined (≥T3) disease.

Conclusions:

• MRI is a moderately accurate tool for bladder cancer T staging.
• Agreement for differentiating non-invasive versus muscle-invasive disease was good.
• Routine use of gadolinium-enhanced MRI sequences is not necessary for bladder cancer staging.